Biologic, cytogenetic, and molecular factors in mesothelial proliferations

Ultrastructural Pathology
John Hicks

Abstract

Although mesothelioma cases may have peaked in the 1990s in developed countries, it is expected that there will be over 70,000 cases diagnosed in the United States over the next 5 decades. With the industrial expansion in Southeast Asia and China and the continued use of asbestos, an epidemic of mesothelioma cases is anticipated over the next several decades. A considerable amount has been learned about the cytogenetic and molecular genetics of mesotheliomas. However, in-depth studies are needed to further define specific factors that may provide for early diagnosis, surgical treatment, oncologic management, and gene therapy. Serologic markers for surveillance of those with asbestos exposure and at risk for mesothelioma are needed. Targeted therapy using molecular markers and gene therapy may provide a means to reverse mesothelial proliferations or stabilize tumor growth and allow for surgical resection. The future holds great promise in identifying mesothelioma gene expression profiles (genomics, gene microarrays) and proteins (proteomics) that may produce the key to dealing with this dismal and devastating neoplasm.

References

Jun 22, 1999·Thorax·D W Kamp, S A Weitzman
Mar 17, 2001·International Journal of Cancer. Journal International Du Cancer·E KettunenW El-Rifai
Jun 27, 2001·Cancer Genetics and Cytogenetics·A A Sandberg, J A Bridge
Oct 12, 2001·Gene·V ScharnhorstA G Jochemsen
Feb 12, 2002·Seminars in Oncology·Michele CarboneJoseph R Testa
Apr 17, 2003·Journal of the National Cancer Institute·Gavin J GordonRaphael Bueno
Oct 22, 2003·Virchows Archiv : an International Journal of Pathology·Lea PylkkänenKirsti Husgafvel-Pursiainen
Nov 25, 2003·Lancet·Bruce W S RobinsonIngegerd Hellstrom
Dec 4, 2003·Mutation Research·Riccardo PuntoniStefano Bonassi
Dec 25, 2003·Archives of Pathology & Laboratory Medicine·Yun-Cai CaiArmando E Fraire
Jan 13, 2004·Biochemical and Biophysical Research Communications·Jiri NeuzilNina Gellert
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Harvey I PassSorin Draghici
Apr 28, 2004·The American Journal of Pathology·Joost P J J HegmansBart N Lambrecht
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raffit HassanIra Pastan
Jul 20, 2004·Clinical Microbiology Reviews·Regis A Vilchez, Janet S Butel
Jul 21, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Michael KrismannGeorg Johnen
Jul 21, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jacobus A Burgers, Ronald A M Damhuis
Oct 27, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chong-Xian PanLiang Cheng
Nov 2, 2004·Oncogene·Luciano Mutti, V Courtney Broaddus

❮ Previous
Next ❯

Citations

Jan 14, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jun ZhongMichael Roth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Hematology/oncology Clinics of North America
Raffit Hassan, Richard Alexander
JBR-BTR : Organe De La Société Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)
J MarrannesJ Verheezen
American Journal of Industrial Medicine
Elodie CamiadeAude Lacourt
Cancer Biology & Therapy
Sandra P D'Angelo, M Catherine Pietanza
© 2021 Meta ULC. All rights reserved